Bill Reddick

Bill Reddick is a seasoned executive with decades of experience in starting, funding and operating companies across the finance and healthcare industries. Most recently, Bill was the founder and CFO of Celtaxsys, a privately held drug discovery and development company, where he guided the lead asset, a drug for cystic fibrosis, through Phase 3. Celtaxsys raised over $80 million in capital, including a $40 million Series D. Prior to Celtaxsys Bill founded Masters Capital Management, a hedge fund that invests in public and private domestic and international bonds and equities. Under Bill’s management assets increased from $700,000 to $650,000,000 between 1994 and 2005. Bill is passionate about the science and business of disease and healing and is committed to turning scientific innovation into therapies for patients.